Nature Search

Author Correction: Hepatic immune regulation and sex disparities

Patrizia Burra
Alberto Zanetto
Frank Tacke
Amendments and Corrections10 Oct 2024
Nature Reviews Gastroenterology & Hepatology

Volume: 21, P: 887
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

Optimizing COVID-19 vaccination strategies for patients under immunosuppressive medication is of high importance. In this clinical trial including non-seroconverted immunosuppressed patients, a homologous mRNA booster vaccination resulted in higher seroconversion rate than a switch to a vector-based vaccine.

Daniel Mrak
Daniela Sieghart
Michael Bonelli
ResearchOpen Access12 Sept 2022
Nature Communications

Volume: 13, P: 1-9
Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center

Johannes Bernhard
Michael Schwarz
Mathias Jachs
ResearchOpen Access29 Oct 2024
Scientific Reports

Volume: 14, P: 1-8
Guideline-conform statin use reduces overall mortality in patients with compensated liver disease

Lukas W. Unger
Bernadette Forstner
Thomas Reiberger
ResearchOpen Access12 Aug 2019
Scientific Reports

Volume: 9, P: 1-10
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis

Juan M. Pericàs
Quentin M. Anstee
Joan Genescà
Amendments and Corrections05 Aug 2024
Nature Reviews Gastroenterology & Hepatology

Volume: 21, P: 824
Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis

Obesity is associated with leptin resistance and rising blood leptin levels while central leptin exposure may be limited. Here, the authors show that brain leptin infusion reduces hepatic lipid content in rats by increasing hepatic VLDL secretion and lowering liver de novo lipogenesis via a vagal mechanism.

Martina Theresa Hackl
Clemens Fürnsinn
Thomas Scherer
ResearchOpen Access20 Jun 2019
Nature Communications

Volume: 10, P: 1-13
Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study

Larissa Nixdorf
Lukas Hartl
Gerhard Prager
ResearchOpen Access30 Jul 2024
Scientific Reports

Volume: 14, P: 1-11
Hepatic immune regulation and sex disparities

Immune dysregulation is a main feature of chronic liver disease, whose burden increases worldwide. This Review discusses the influence of biological sex in hepatic immune mechanisms in the context of liver disease and identifies sex disparities in research and therapeutics.

Patrizia Burra
Alberto Zanetto
Frank Tacke
Reviews05 Sept 2024
Nature Reviews Gastroenterology & Hepatology

Volume: 21, P: 869-884
A roadmap for clinical trials in MASH-related compensated cirrhosis

Metabolic dysfunction-associated steatohepatitis (MASH), a primary cause of chronic liver disease (CLD), often leads to advanced CLD stages such as cirrhosis. This Roadmap summarizes the current landscape and challenges of MASH-related compensated cirrhosis clinical trials and explores a way forward for future studies.

Juan M. Pericàs
Quentin M. Anstee
Joan Genescà
Reviews17 Jul 2024
Nature Reviews Gastroenterology & Hepatology

Volume: 21, P: 809-823
The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Lukas Hartl
Benedikt Rumpf
Thomas Reiberger
ResearchOpen Access18 Jan 2023
Scientific Reports

Volume: 13, P: 1-11
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats

Philipp Schwabl
Ksenia Brusilovskaya
Thomas Reiberger
ResearchOpen Access19 Jun 2018
Scientific Reports

Volume: 8, P: 1-13
Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis

Katharina Staufer
Heidemarie Huber
Wolfgang Mikulits
ResearchOpen Access02 Aug 2023
Cell Death Discovery

Volume: 9, P: 1-8
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure

Patrick Haselwanter
Bernhard Scheiner
Mathias Schneeweiss-Gleixner
ResearchOpen Access17 May 2024
Scientific Reports

Volume: 14, P: 1-12
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma

Nataliya Rohr-Udilova
Florian Klinglmüller
Michael Trauner
ResearchOpen Access18 Apr 2018
Scientific Reports

Volume: 8, P: 1-11
Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction

Daniel Dalos
Christina Binder
Diana Bonderman
ResearchOpen Access06 Dec 2019
Scientific Reports

Volume: 9, P: 1-9
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis

This protocol describes a syngeneic orthotopic hepatocellular carcinoma (HCC) model in immunocompetent mice with liver cirrhosis induced by carbon tetrachloride. This model recapitulates the key features of the necroinflammatory, fibrotic and angiogenic microenvironment of human HCC.

Thomas Reiberger
Yunching Chen
Dan G Duda
Protocols23 Jul 2015
Nature Protocols

Volume: 10, P: 1264-1274

Search

Filter By:

Search

Quick links